NCT01295021
- Conditions
- Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
- Locations
-
- Research Site Agartala, India
- Research Site Agra, India
- Research Site Ahmedabad, India
- Research Site Aligarh, India
Clinical trial condition
Hypertension
Explore clinical trials studying Hypertension. Study availability and eligibility vary by location and protocol.
1,086 public trials
179 recruiting studies
Hypertension trial results
NCT01121458
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- VA North Texas Health Care System Dallas, Texas, United States
NCT01538875
- Conditions
- Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypertension, +5 more
- Locations
-
- Saint Thomas Maternity Hospital Panama City, Provincia de Panamá, Panama
Completed
Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration
NCT01352065
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- Center for Health, Exercise and Sport Sciences Belgrade, Serbia
NCT00138944
- Conditions
- Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
- Locations
-
- CRC Medical Department IV Erlangen, Germany
NCT00657722
- Conditions
- Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension, Hypertension, +4 more
- Locations
-
- Hôpital Antoine Beclere Clamart, France
- Hospital Marie Lannelongue Le Plessis-Robinson, France
NCT00549302
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bend, Oregon, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
NCT01139710
- Conditions
- Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hypersensitivity, +10 more
- Locations
-
- Meir MC Kfar Saba, Israel
Completed
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
NCT00058929
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +5 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Harbor-UCLA Medical Center Torrance, California, United States
- The Rush Heart Institute Center for Pulmonary Heart Disease Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
NCT01783093
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
- Locations
-
- The Ohio State University Medical Center Columbus, Ohio, United States